BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11848531)

  • 1. Assessment of soft tissue lesions suspicious for liposarcoma by F18-deoxyglucose (FDG) positron emission tomography (PET).
    Schwarzbach MH; Dimitrakopoulou-Strauss A; Mechtersheimer G; Hinz U; Willeke F; Cardona S; Attigah N; Strauss LG; Herfarth C; Lehnert T
    Anticancer Res; 2001; 21(5):3609-14. PubMed ID: 11848531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.
    Schwarzbach MH; Dimitrakopoulou-Strauss A; Willeke F; Hinz U; Strauss LG; Zhang YM; Mechtersheimer G; Attigah N; Lehnert T; Herfarth C
    Ann Surg; 2000 Mar; 231(3):380-6. PubMed ID: 10714631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grading liposarcomas with PET using [18F]FDG.
    Adler LP; Blair HF; Williams RP; Pathria MN; Makley JT; Joyce MJ; al-Kaisi N; Miraldi F
    J Comput Assist Tomogr; 1990; 14(6):960-2. PubMed ID: 2229575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible?
    Schulte M; Brecht-Krauss D; Heymer B; Guhlmann A; Hartwig E; Sarkar MR; Diederichs CG; Schultheiss M; Kotzerke J; Reske SN
    Eur J Nucl Med; 1999 Jun; 26(6):599-605. PubMed ID: 10369945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma.
    Nieweg OE; Pruim J; van Ginkel RJ; Hoekstra HJ; Paans AM; Molenaar WM; Koops HS; Vaalburg W
    J Nucl Med; 1996 Feb; 37(2):257-61. PubMed ID: 8667056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma.
    Suzuki R; Watanabe H; Yanagawa T; Sato J; Shinozaki T; Suzuki H; Endo K; Takagishi K
    Ann Nucl Med; 2005 Dec; 19(8):661-70. PubMed ID: 16444991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading.
    Dimitrakopoulou-Strauss A; Strauss LG; Schwarzbach M; Burger C; Heichel T; Willeke F; Mechtersheimer G; Lehnert T
    J Nucl Med; 2001 May; 42(5):713-20. PubMed ID: 11337565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
    Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between F-18 FDG PET/CT and pathological findings in soft tissue lesions.
    Nose H; Otsuka H; Otomi Y; Terazawa K; Takao S; Iwamoto S; Harada M
    J Med Invest; 2013; 60(3-4):184-90. PubMed ID: 24190034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment in liposarcoma patients based on FDG PET imaging.
    Brenner W; Eary JF; Hwang W; Vernon C; Conrad EU
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1290-5. PubMed ID: 16832631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET/CT findings in rare sarcomas.
    Ergül N; Aydın M
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):324-7. PubMed ID: 23352751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
    Inoue T; Kim EE; Wong FC; Yang DJ; Bassa P; Wong WH; Korkmaz M; Tansey W; Hicks K; Podoloff DA
    J Nucl Med; 1996 Sep; 37(9):1472-6. PubMed ID: 8790196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive grading of musculoskeletal tumors using PET.
    Adler LP; Blair HF; Makley JT; Williams RP; Joyce MJ; Leisure G; al-Kaisi N; Miraldi F
    J Nucl Med; 1991 Aug; 32(8):1508-12. PubMed ID: 1869970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography with fluorine-18-fluorodeoxyglucose for the evaluation of therapeutic isolated regional limb perfusion in a patient with soft-tissue sarcoma.
    Nieweg OE; Pruim J; Hoekstra HJ; Paans AM; Vaalburg W; Oldhoff J; Schraffordt Koops H
    J Nucl Med; 1994 Jan; 35(1):90-2. PubMed ID: 8271067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography.
    Lucas JD; O'Doherty MJ; Cronin BF; Marsden PK; Lodge MA; McKee PH; Smith MA
    Br J Surg; 1999 Apr; 86(4):550-6. PubMed ID: 10215835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
    Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C
    Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine.
    Buck AK; Herrmann K; Büschenfelde CM; Juweid ME; Bischoff M; Glatting G; Weirich G; Möller P; Wester HJ; Scheidhauer K; Dechow T; Peschel C; Schwaiger M; Reske SN
    Clin Cancer Res; 2008 May; 14(10):2970-7. PubMed ID: 18445694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
    Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
    Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
    J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating benign and malignant pulmonary lesions with FDG-PET.
    Yang SN; Liang JA; Lin FJ; Kwan AS; Kao CH; Shen YY
    Anticancer Res; 2001; 21(6A):4153-7. PubMed ID: 11911310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.